Calendar Mereo BioPharma Group plc London S.E.

Equities

MPH

GB00BZ4G2K23

Delayed London S.E. 5-day change 1st Jan Change
- GBX -.--% Intraday chart for Mereo BioPharma Group plc -10.17% -.--%

Chart calendar Mereo BioPharma Group plc

9914a7b910bab.zLGIsbmu1_qoPPwj6PffaIpnVWnmtqb1-HfPYNQC8wI.iYfj7vXqgbjjVZIXnaCHHOQrESXX3teQyk6HNKNsgHHh5PvDiJfkvoVJpQ~e9a62c0b6f9e4e1aca30221a55de1dbf

Upcoming events on Mereo BioPharma Group plc

17/09/2024 Q2 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
23/09/2025 Q2 2025 Earnings Release (Projected)
01/04/2026 Q4 2025 Earnings Release (Projected)

Past events on Mereo BioPharma Group plc

09/04/2024 07:45 pm Needham Healthcare Conference - Fireside Chat
28/03/2024 01:31 am Q4 2023 Earnings Release
12/03/2024 08:50 pm Leerink Partners Global Biopharma Conference - Fireside Chat
20/10/2023 European Society for Medical Oncology Congress
27/09/2023 08:25 pm Cantor Global Healthcare Conference - Fireside Chat
07/09/2023 05:00 pm Q2 2023 Earnings Release
08/06/2023 07:00 pm Jefferies Global Healthcare Conference
23/05/2023 06:30 pm American Thoracic Society International Conference - Abstract No 10172
22/05/2023 06:30 pm American Thoracic Society International Conference - Abstract No 10358
20/04/2023 06:15 pm Needham Healthcare Conference
29/03/2023 02:00 am Q4 2022 Earnings Release
21/03/2023 06:00 pm Business Update Call
15/02/2023 06:30 pm SVB Securities Global Biopharma Conference
18/11/2022 07:30 pm Extraordinary Shareholders Meeting - Proxy Fight for Board Representation
15/11/2022 06:25 pm Jefferies London Healthcare Conference - Fireside Chat
31/10/2022 05:30 pm R&D Day
05/06/2022 06:30 pm American Society of Clinical Oncology Meeting - Abstract No. 2651
09/05/2022 08:00 pm ASTRAEUS Phase 2 Clinical Study Results Call
13/04/2022 10:15 pm Needham Virtual Healthcare Conference
01/04/2022 01:31 am FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
36,5
24,3
49.93%
0,00
0,00
-
10,0
7,93
26.18%

27,5

EBITDA
Million GBP
Released
Forecast
Spread
0,00
0,00
-
-36,0
-34,9
-3.06%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million GBP
Released
Forecast
Spread
-39,5
-38,3
-3.1%
-37,6
-35,3
-6.43%
-20,9
-36,6
42.8%
-43,6
-43,3
-0.69%
-28,4
-27,9
-2.03%

-38,0

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
-41,1
-40,5
-1.44%
-166
-145
-14.66%
14,2
-8,10
275.9%
-36,1
-42,1
14.33%
-30,0
-28,2
-6.31%

-29,5

Net income
Million GBP
Released
Forecast
Spread
-34,8
-39,2
11.19%
-164
-143
-14.25%
12,7
-9,31
236.74%
-34,2
-41,4
17.38%
-29,5
-27,9
-5.43%

-8,27

EPS
GBP
Released
Forecast
Spread
0,00
0,00
-
-2,41
-0,52
-363.46%
0,02
-0,02
252.67%
-0,06
-0,07
14.29%
-0,04
-0,04
5.88%

-0,01

Announcement Date15/06/2031/03/2131/03/2228/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales
Million GBP
Released
Forecast
Spread
0,00
0,00
-
0,00
3,20
-
0,00
0,00
-
36,5
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

0,00
0,00
-
0,00
0,00
-

0,00


0,00

0,00
0,00
-
7,13
0,00
-
2,87
0,00
-

12,5


15,0


0,00


0,00

EBIT
Million GBP
Released
Forecast
Spread
-21,1
-18,9
-11.83%
-16,7
-18,1
7.78%
-20,9
-16,9
-23.54%
-0,20
-18,0
98.87%
-10,4
-16,0
35.19%
-20,7
-19,0
-9.12%






-21,8
-18,8
-16.01%






-21,8
-20,1
-8.25%
-9,91
-11,0
9.92%
-18,5
-18,0
-3.1%

-18,6


-19,4







Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
-22,4
-18,9
-18.71%
-126
-18,1
-596.69%
-40,3
-16,9
-138.75%
10,9
-18,0
160.58%

-16,0

3,34
-19,0
117.56%






-19,9
-19,0
-4.7%






-16,2
-20,3
20.2%
-11,9
-11,0
-8.52%
-18,1
-16,3
-10.8%

-14,6


-14,9


-15,0


-15,0

Net income
Million GBP
Released
Forecast
Spread
-18,6
-18,9
1.48%
-125
-18,1
-588.5%
-39,0
-16,9
-130.82%
12,1
-18,0
167.16%

-16,0

0,64
-20,8
103.06%






-19,2
-19,0
-0.83%






-15,0
-20,7
27.24%
-11,0
-14,2
22.32%
-18,4
-17,3
-6.57%

-5,05


-3,24


-15,0


-15,0

EPS
GBP
Released
Forecast
Spread






-0,35
-0,05
-600%
0,02
-0,03
174.33%
-0,17
-0,03
-466.67%
0,00
-0,05
101.38%






-0,03
-0,04
14.29%






-0,03
-0,04
18.19%
-0,02
-0,02
14.27%
-0,02
-0,03
27.27%

-0,01


0,00


-0,02


-0,02

Announcement Date15/06/2029/09/2031/03/2102/11/2131/03/2231/03/22-02/11/2202/11/22--28/03/2307/09/2327/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MREO Stock
  4. MPH Stock
  5. Calendar Mereo BioPharma Group plc